Agile Therapeutics, Inc. (AGRX)
OTCMKTS: AGRX · Delayed Price · USD
0.400
0.00 (-0.07%)
Apr 25, 2024, 2:00 PM EDT - Market closed
Agile Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 3 | 4,206 | 5 | 1 | 243 | 124 | 20 | 83 | 161 | 215 | 70 | Upgrade
|
| Market Cap Growth | - | 85629.62% | 314.23% | -99.51% | 96.66% | 525.25% | -76.25% | -48.35% | -25.00% | 207.15% | 39.88% | Upgrade
|
| Enterprise Value | 2 | 4,205 | 2 | -0 | 245 | 89 | 12 | 58 | 128 | 196 | 45 | Upgrade
|
| PE Ratio | -323.22 | -290.74 | -0.19 | -0.02 | -4.44 | -6.70 | -1.00 | -2.94 | -5.61 | -7.08 | -4.35 | Upgrade
|
| PS Ratio | 0.14 | 214.65 | 0.45 | 0.29 | 324.48 | - | - | - | - | - | - | Upgrade
|
| PB Ratio | -354.16 | -257.73 | -0.88 | 0.13 | 4.93 | 2.70 | 0.98 | 2.29 | 3.81 | 7.22 | 1.94 | Upgrade
|
| P/FCF Ratio | -603.44 | -439.14 | -0.14 | -0.02 | -5.10 | -7.83 | -1.15 | -3.22 | -6.91 | -8.34 | -4.79 | Upgrade
|
| P/OCF Ratio | -603.44 | -439.14 | -0.14 | -0.02 | -5.14 | -7.88 | -1.17 | -3.39 | -6.92 | -8.43 | -4.82 | Upgrade
|
| EV/Sales Ratio | 0.12 | 214.63 | 0.17 | -0.04 | 327.23 | - | - | - | - | - | - | Upgrade
|
| EV/EBITDA Ratio | -294.44 | -216.54 | -0.05 | 0.00 | -5.03 | -4.80 | -0.66 | -2.18 | -4.32 | -5.92 | -2.41 | Upgrade
|
| EV/EBIT Ratio | -288.76 | -212.32 | -0.04 | 0.00 | -5.00 | -4.76 | -0.66 | -2.18 | -4.32 | -5.92 | -2.41 | Upgrade
|
| EV/FCF Ratio | -603.40 | -439.10 | -0.05 | 0.00 | -5.14 | -5.65 | -0.69 | -2.24 | -5.50 | -7.61 | -3.06 | Upgrade
|
| Debt / Equity Ratio | -0.13 | -0.13 | -0.40 | 1.92 | 0.33 | 0.00 | 0 | 0.29 | 0.38 | 0.52 | 0.41 | Upgrade
|
| Debt / EBITDA Ratio | -0.11 | -0.11 | -0.05 | -0.25 | -0.34 | -0.01 | - | -0.40 | -0.54 | -0.47 | -0.80 | Upgrade
|
| Debt / FCF Ratio | -0.23 | -0.23 | -0.06 | -0.27 | -0.35 | -0.01 | - | -0.41 | -0.69 | -0.60 | -1.02 | Upgrade
|
| Quick Ratio | 0.29 | 0.29 | 0.64 | 0.71 | 7.53 | 9.09 | 3.54 | 2.52 | 4.57 | 4.34 | 4.47 | Upgrade
|
| Current Ratio | 0.46 | 0.46 | 0.85 | 0.82 | 7.72 | 9.31 | 3.81 | 2.57 | 4.82 | 4.80 | 4.56 | Upgrade
|
| Asset Turnover | 1.68 | 1.91 | 0.76 | 0.10 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Coverage | -13.29 | -14.01 | -13.23 | -18.14 | -15.78 | 0 | -17.50 | -13.98 | -12.76 | -15.97 | -11.85 | Upgrade
|
| Return on Equity (ROE) | 77.75% | 88.64% | 458.29% | -826.07% | -110.86% | -40.32% | -98.04% | -77.92% | -67.96% | -101.99% | -44.65% | Upgrade
|
| Return on Assets (ROA) | -123.73% | -141.05% | -178.43% | -194.71% | -74.85% | -37.23% | -88.33% | -55.94% | -45.00% | -59.82% | -29.32% | Upgrade
|
| Return on Capital (ROIC) | 140.58% | 140.56% | 1242.77% | -262.37% | -74.50% | -41.07% | -96.83% | -57.13% | -50.99% | -73.10% | -36.42% | Upgrade
|
| Earnings Yield | -462.64% | -0.34% | -518.01% | -6466.75% | -22.50% | -14.92% | -100.07% | -34.01% | -17.83% | -14.12% | -22.98% | Upgrade
|
| FCF Yield | -349.21% | -0.23% | -735.47% | -5528.30% | -19.61% | -12.77% | -87.09% | -31.09% | -14.48% | -11.99% | -20.87% | Upgrade
|
| Buyback Yield / Dilution | -359283.18% | -498890.32% | -35520.10% | 97.13% | -71.31% | -44.06% | -10.90% | -9.44% | -28.42% | -93.22% | -16.93% | Upgrade
|
| Total Shareholder Return | -359283.18% | -498890.32% | -35520.10% | 97.13% | -71.31% | -44.06% | -10.90% | -9.44% | -28.42% | -93.22% | -16.93% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.